Mary Klotman, MD, Talks with Kanecia Zimmerman, MD, PhD, MPH, who is Duke's principal investigator for the Clinical Trials Data Coordinating Center for research on Long COVID.

Duke researchers spearhead JAMA Surgery study showing men overwhelmingly hold the top spots in U.S. medical school surgical leadership

A vaccine designed to protect against three different deadly coronaviruses shows success in mouse studies, demonstrating the viability of a pan-coronavirus vaccine developed by researchers at the Duke Human Vaccine Institute.

The School of Medicine’s new employee resource group ¡DALHE! Kicked off its inaugural event recognizing Hispanic Heritage Month on Friday, October 6.

Everardo Macias's quest to find innovative treatments for prostate cancer mirrors his own incredible journey – from a migrant farm worker to a groundbreaking scientist.

The School of Medicine kicked off a new restorative justice pilot program with participants from across School of Medicine departments and units.

Mary E. Klotman, MD, Executive Vice President for Health Affairs, Duke University; Dean, Duke University School of Medicine, and Chief Academic Officer, Duke Health and Craig Albanese, MD, MBA, Chief Executive Officer, Duke University Health System detail how they're working together to build deeper alignment between Duke’s clinical, academic, research and global health missions, and establish a unified system in which each part enhances the other.

Immunologists identify a pivotal protein in the progression of MS. Could blocking it be the future of treatment?

A host of luminaries, including seven Nobel Laureates, two former chancellors, and scores of Robert J. Lefkowitz’s former trainees gather to celebrate his 50 years at Duke.

Research finds younger African American women with triple-negative breast cancer may have a molecularly distinct form of the disease that makes it more aggressive.